| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period | 
|---|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | Director | $448K | Jun 1, 2025 | ||
| TRIL | Trillium Therapeutics Inc. | Chief Financial Officer | Nov 17, 2021 | 
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership | 
|---|